OverviewSuggest Edit

Nuo Therapeutics, Inc. is a biomedical company that pioneers leading-edge biodynamic therapies within the emerging opportunities of a changing healthcare landscape.

Nuo Therapeutics’ flagship product, Aurix, is a biodynamic hematogel that uses a patient’s own platelets and plasma as a catalyst for healing. It is the only therapy of its kind that is FDA-cleared for use on ulcers and wounds of all types.

... Show more
TypePublic
HQGaithersburg, US
Websitenuot.com
Employee Ratings3.2

Locations

Nuo Therapeutics is headquartered in
Gaithersburg, United States

Location Map

Latest Updates

Employees (est.) (Sep 2015)46
Revenue (FY, 2017)$721 K(+53%)

Key People/Management at Nuo Therapeutics

Peter A. Clausen

Peter A. Clausen

Ph.D., Chief Science Officer
David E. Jorden

David E. Jorden

CPA, Chief Executive Officer & Chief Financial Officer
Show more

Nuo Therapeutics Office Locations

Nuo Therapeutics has an office in Gaithersburg
Gaithersburg, US (HQ)
1 207A Perry Pkwy
Show all (1)
Report incorrect company information

Nuo Therapeutics Financials and Metrics

Nuo Therapeutics Revenue

Nuo Therapeutics's revenue was reported to be $721.05 k in FY, 2017
USD

Revenue (Q3, 2018)

260.3k

Net income (Q3, 2018)

(649.9k)

EBIT (Q3, 2018)

(411.8k)

Cash (30-Sep-2018)

250.2k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

11.6m7.8m11.5m472.4k721.0k

Revenue growth, %

(33%)48%(96%)

Cost of goods sold

8.4m6.6m

Gross profit

3.2m1.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

3.4m1.8m2.3m1.7m4.8m2.9m2.2m1.4m134.9k176.8k172.7k188.6k162.2k159.9k138.3k260.3k

Cost of goods sold

2.8m1.4m1.9m1.3m

Gross profit

548.8k437.1k473.1k401.6k

Gross profit Margin, %

16%24%20%24%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.3m15.9m922.3k2.6m693.5k

Inventories

1.1m2.3m254.4k70.0k35.6k

Current Assets

10.0m21.9m3.0m3.4m1.2m

PP&E

919.5k925.2k1.1m486.1k223.6k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(20.2m)(18.9m)(52.8m)(5.7m)(15.0m)

Depreciation and Amortization

1.1m613.5k741.0k836.2k1.1m

Inventories

58.6k(1.1m)272.0k(21.6k)19.4k

Accounts Payable

5.2m(1.5m)(811.0k)(2.5m)(12.3k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(15.4m)(5.6m)(17.0m)(21.7m)4.1m3.2m(10.6m)(4.9m)(1.3m)(1.9m)(1.7m)(1.4m)(670.2k)(1.3m)(1.9m)

Depreciation and Amortization

875.1k217.7k438.6k481.1k345.7k532.7k208.6k310.0k26.1k51.8k77.0k

Inventories

(631.8k)380.0k519.9k566.8k(173.7k)(60.4k)95.8k4.3k367.5k(2.6k)(2.8k)(4.9k)

Accounts Payable

2.4m(78.1k)(689.4k)(1.7m)2.0m(139.6k)632.2k926.3k1.3m498.3k(14.3k)434.5k156.0k143.2k100.7k
USDY, 2018

Financial Leverage

-1.3 x
Show all financial metrics
Report incorrect company information

Nuo Therapeutics Company Life and Culture

Report incorrect company information

Nuo Therapeutics Frequently Asked Questions

  • Who are Nuo Therapeutics key executives?

    Nuo Therapeutics's key executives are Peter A. Clausen and David E. Jorden.

  • How many employees does Nuo Therapeutics have?

    Nuo Therapeutics has 46 employees.

  • What is Nuo Therapeutics revenue?

    Latest Nuo Therapeutics annual revenue is $721 k.

  • What is Nuo Therapeutics revenue per employee?

    Latest Nuo Therapeutics revenue per employee is $15.7 k.

  • Who are Nuo Therapeutics competitors?

    Competitors of Nuo Therapeutics include Pierrel, Oncoinvent and ARMO BioSciences.

  • Where is Nuo Therapeutics headquarters?

    Nuo Therapeutics headquarters is located at 1 207A Perry Pkwy, Gaithersburg.

  • Where are Nuo Therapeutics offices?

    Nuo Therapeutics has an office in Gaithersburg.

  • How many offices does Nuo Therapeutics have?

    Nuo Therapeutics has 1 office.